TIMP-GLIA

N/A

Report date: 2025/06/19 20:00:08

Base Information

Drug NameTIMP-GLIA
Drug Alias NameTIMP GLIACour-NP-GLITIMP/GliadinToleragenic Immune Modifying nanoParticles - coeliac diseaseTAK-101 +[6] 
ClassificationNatural product/Extract > Animal extractBiologics
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsCeliac Disease
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited StatesNew Zealand +[4] 
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesCour Pharmaceutical Development
China Registration ClassN/A

Develop Information

Active CompaniesTakeda Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCeliac Disease
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A